Advertisement|Remove ads.

Advertisement|Remove ads.
UnitedHealth Group Inc. (UNH) shares gained more than 7% in pre-market trading on Tuesday after a strong quarter, but more importantly, its outlook shift and improved margin signals caught investors' attention. The insurer raised its full-year 2026 earnings outlook and announced a $2 billion share buyback.
UnitedHealth raised its FY2026 adjusted earnings guidance to more than $18.25 per share. It had previously guided for earnings of $17.75 per share. This is above Wall Street’s estimates of $17.87 per share, according to Fiscal.ai.
The company also announced plans to repurchase at least $2 billion worth of its shares by the end of the second quarter (Q2) under its existing buyback program.
Advertisement|Remove ads.
UnitedHealth Group’s first quarter (Q1) revenues came in 1.9% higher at $111.7 billion, beating Street estimates. The insurer’s Q1 adjusted net earnings of $7.23 per share were well above the consensus estimates of $6.61 per share.
UnitedHealth Group’s medical cost ratio (MCR) was 83.9% for Q1, down 90 basis points from last year. The MCR improved by 20 basis points due to a previously disclosed reserve related to loss-making Optum Health contracts, the company said. The MCR represents the share of revenue spent on medical claims; a higher ratio indicates that costs are rising faster than revenue.
The company said Q1 operating margin increased to 6.6% from 6.% a year earlier, primarily driven by pricing adjustments across all business segments to offset elevated cost trends seen in the insurance space.
Advertisement|Remove ads.
UnitedHealth also mentioned that its acquisition of Alegeus Technologies to expand its consumer-focused healthcare solutions is expected to close in late 2026.
Retail sentiment on Stocktwits for UNH flipped to ‘extremely bullish’ from ‘neutral’ a day earlier, amid ‘high’ message volumes. UNH was also among the top trending tickers at the time of writing.
One user expects the stock to climb to $500 by the end of the year.
Advertisement|Remove ads.
Another user expects a multi-day run on the back of the Q1 results.
Advertisement|Remove ads.
Earlier this month, Morgan Stanley named UnitedHealth as ‘Top Pick’, adding that it “is not necessarily a call on the quarter, but a call on what should be a string of clean quarters that should drive incremental enthusiasm.”
Meanwhile, Jefferies raised its price target to $373 from $340 and maintained a ‘Buy’ rating, according to The Fly.
UNH stock has shed around 2% so far this year.
Advertisement|Remove ads.
For updates and corrections, email newsroom[at]stocktwits[dot]com.
Comments posted here will also appear on symbol pages.